These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8066063)
61. An HPLC method for the simultaneous analysis of urinary neopterin and kynurenine. Marfella A; Polese C; d'Alessio P; Beneduce G; Rossi F; Perna M Pharmacol Res; 1992 Sep; 26 Suppl 2():174-5. PubMed ID: 1409297 [No Abstract] [Full Text] [Related]
62. Association between the activation of macrophages, changes of iron metabolism and the degree of anaemia in patients with malignant disorders. Denz H; Huber P; Landmann R; Orth B; Wachter H; Fuchs D Eur J Haematol; 1992 May; 48(5):244-8. PubMed ID: 1644156 [TBL] [Abstract][Full Text] [Related]
66. The potential role of granulocyte-macrophage colony stimulating factor in therapy of fungal infections: a commentary. Bodey GP Eur J Clin Microbiol Infect Dis; 1994 May; 13(5):363-6. PubMed ID: 8070447 [No Abstract] [Full Text] [Related]
68. Neopterin as a biomarker of immune response in cancer patients. Melichar B; Spisarová M; Bartoušková M; Krčmová LK; Javorská L; Študentová H Ann Transl Med; 2017 Jul; 5(13):280. PubMed ID: 28758106 [TBL] [Abstract][Full Text] [Related]
69. [GM-CSF and G-CSF: cytokines in clinical application]. Ruef C; Coleman DL Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294 [TBL] [Abstract][Full Text] [Related]
70. [Increase of neopterin after treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF)]. Melichar B; Solichova D; Jebavy L Presse Med; 1994 Mar; 23(12):581. PubMed ID: 8066063 [No Abstract] [Full Text] [Related]
71. Increased production of immune activation marker neopterin by colony-stimulating factors in gynecological cancer patients. Marth C; Weiss G; Koza A; Reibnegger G; Daxenbichler G; Zeimet AG; Fuchs D; Wachter H; Dapunt O Int J Cancer; 1994 Jul; 58(1):20-3. PubMed ID: 7516925 [TBL] [Abstract][Full Text] [Related]
72. Phase II study of recombinant human granulocyte-macrophage colony-stimulating factor in myelodysplastic syndrome and aplastic anemia. Takahashi M; Yoshida Y; Kaku K; Masaoka T; Moriyama Y; Nakanishi S; Kaneko T; Shibata A; Miwa S Acta Haematol; 1993; 89(4):189-94. PubMed ID: 8212999 [TBL] [Abstract][Full Text] [Related]
73. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)]. Kitamura K; Asano S; Mizoguchi H; Takaku F Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327 [TBL] [Abstract][Full Text] [Related]
74. Clinical applications of human granulocyte-macrophage colony-stimulating factor. Sakamoto KM; Gasson JC Int J Cell Cloning; 1991 Nov; 9(6):531-41. PubMed ID: 1770227 [TBL] [Abstract][Full Text] [Related]
75. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses. Wu HH; Talpaz M; Champlin RE; Pilat SR; Kurzrock R Cancer; 2003 Dec; 98(11):2410-9. PubMed ID: 14635076 [TBL] [Abstract][Full Text] [Related]